Just a caveat in a world that I am sure you really know nothing about. All those "business" factors go towards growth and development, and are great metrics to determine future individual investments in the market. However, you miss the big boat here. Medical Device companies start somewhere. They raise capital first, then prove out their model and products. Not the other way around. Most new Medical device companies are pre-revenue, yet attract hundreds of millions o dollars in funding, why, because their products and business model demonstrate value to initial funders. So while your metrics are right for existing companies with existing products, its irrelevant to any bankers analysis of funding an new innovative medical products company, and this is where you miss the boat.
Costs millions of dollars in development and testing medical devices, not $50K. I am going to be very curious if the company announces funding with a banker, what your analysis will be then. Wasn't worth it? Good thing for us, very smart bankers will be conducting their own analysis, not relying on yours in making their decisions. If they fund, or underwrite the funding, you will have your answer, and if you don't agree, then you can move on. Why wait though? You should just move on now. I am sure there are hundreds of other OTC companies you could feel very comfortable with.
Actually YD is of the same mindset. We invite you guys back in a few months to see who's right.
